Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-03-01
1999-07-27
Wortman, Donna C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A01N 5502
Patent
active
059290650
ABSTRACT:
The invention relates to a method of treating sleep disorders in a patient in need thereof comprising the administration of a hypnotically effective amount of a non-allosteric GABA.sub.A agonist.
REFERENCES:
patent: 4362731 (1982-12-01), Hill
patent: 4786647 (1988-11-01), Simpkins et al.
patent: 5167228 (1992-12-01), Czeisler et al.
patent: 5354760 (1994-10-01), Petersen et al.
Tominaga et al., "GABA A receptor agonist muscimol can reset the phase of ural activity rhythm in the rat suprachiasmatic nucleus in vitro", Neuroscience Letters, 166:81-84, 1994.
LLoyd et al., "The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trials", Pharamacology Biochemistry and Behavior, 18:957-966, 1983.
de Bittencourt et al., "Vigabatrin: clinical evidence supporting rational polytherapy in management of uncontrolled seizures", Epilepsia, 35(2):373-380, 1994.
Camacho-Arroyo et al., Neuroscience Letters; 129(1):95-97, Aug. 5, 1991.
LLoyd et al., Pharmacology Biochemistry & Behavior, 18:957-966, 1983.
Chweh, A.Y. et al. (1987) "Hynoptic Action Of Pentobarbital In Mice: A Possible Mechanism," Expt. Neurology 97:70-76.
Depaulis, A. et al. (1988) "Evidence That Activation Of GABA Receptors In the Substantia Nigra Suppresses Spontaneous Spike-And-Wave Discharge In The Rat," Brain Research 448:20-29.
Fariello, R.G. et al. (1984) "Metabolic Correlates Of GABAmimetic-Induced EEG Abnormalities," in Neurotransmitter. Seizures and Epilepsy, R.G. Fariello et al., eds, Raven Press, New York, pp. 245-252.
Lancel, M. And Faulhaber, J. (1996) "The GABA.sub.A Agonist THIP (gaboxadol) Increases Non-REM Sleep And Enhances Delta Activity In The Rat," NeuroReport 7:2241-2245.
Brumback Brenda G.
Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.v.
White John P.
Wortman Donna C.
LandOfFree
Method for treating sleep disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating sleep disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating sleep disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-878913